Rare Disease and Orphan Drug Situations in Turkey and around the World

Home Page
About
Submit A Journal
Submit A Conference
Submit Paper/Book
- Submit a Preprint
- Submit a Book
Contact

Aurum Journal of Health Sciences
Volume:1 Issue:2
Rare Disease and Orphan Drug Situations in Turkey and around the World

Rare Disease and Orphan Drug Situations in Turkey and around the World

Authors : Buket AKSU

Pages : 95-109

View : 58 | Download : 13

Publication Date : 2019-03-31

Article Type : Other Papers

Abstract :Abstract: Diseases with a prevalence less than 1/2000 are defined as “Rare Diseases”. This group of diseases is a highly heterogeneous group that affects multiple systems. Approximately 80% of these are caused by genetic reasons, and the remaining 20% are caused by environmental factors or are idiopathic. Orphan drug is defined as a medicinal product designed for a life-threatening or chronically impairing rate disease but with a low possibility of obtaining a return on investment due to insufficient sales. In Turkey, where consanguineous marriage frequency is 25% on average, the probability of rare diseases is quite high. Lack of knowledge and specialist physicians, very expensive treatments, and lack of a designated regulation for rare diseases and orphan drugs are the main problems in our country. The research revealed that orphan drugs were imported to Turkey through the Turkish Pharmacists’ Association insert ignore into journalissuearticles values(TEB); and not covered by Social Security, therefore making it hard for the patients with low income to reach these drugs.
Keywords : Rare, disease, orphan, drug

ORIGINAL ARTICLE URL

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.